Bently P Doonan

6PUBLICATIONS
51CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 24, 2026
Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.

|Feb 03, 2026
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

George Ansstas, Karam Khaddour, Sumedha Sudhaman

|Nov 11, 2025
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors.

Sheila Carrera-Justiz, Mahya Aghaee, Sadeem Qdaisat

|Feb 26, 2025
Using a Natural Triterpenoid to Unlock the Antitumor Effects of Autophagy in B-Cell Lymphoma.

Bently P Doonan, Faisal F Y Radwan, Naren L Banik

|Jul 12, 2024
Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade.

Christina A von Roemeling, Jeet A Patel, Savannah L Carpenter

|Feb 07, 2023
Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases.

Christina A Von Roemeling, Bently P Doonan, Kelena Klippel

Pageof 1

Frequent Collaborators

3 joint publications

Christina A Von Roemeling

3 joint publications

Duane A Mitchell

2 joint publications

Vrunda Trivedi

1 joint publications

Sheila Carrera-Justiz